Ultrasound in Rare Diffuse Liver Disease

A. P. Barreiros; L. Chiorean; B. Braden; C. F. Dietrich

doi:10.1055/s-0034-1384996

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2014; 52(11): 1247-1256
DOI: 10.1055/s-0034-1384996

Originalarbeit

Ultrasound in Rare Diffuse Liver Disease

Ultraschall seltener diffuser Lebererkrankungen

A. P. Barreiros

¹Medical Department I, University Hospital, University of Regensburg, Regensburg, Germany

,

L. Chiorean

²Department of Ultrasonography, “Octavian Fodor” Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania

,

B. Braden

³Translational Gastroenterology Unit, Oxford University Hospitals, Oxford, U. K.

,

C. F. Dietrich

⁴Medical Department II, Caritaskrankenhaus, Bad Mergentheim, Germany

› Author Affiliations

Abstract

Ultrasound is often the first imaging procedure performed in the evaluation of individuals with suspected or known liver disease. Despite technical advances in ultrasound techniques, sonographic detection and evaluation of diffuse liver disease still remains difficult. This is due to the fact that diffuse liver disease does not always cause distortion of the liver parenchymal texture, internal liver architecture, or shape of the liver. On the other hand, the size of the liver, the echo pattern of the hepatic parenchyma, the analysis of intrahepatic vessels and alterations in perihepatic structures and lymph nodes can be helpful sonographic parameters of diffuse liver disease. Until now, the sonographic appearance of some rare diffuse liver diseases is not well known. However, there are some typical sonomorphological signs that, once identified, can facilitate the differentiation between various diseases. The aim of this paper is to highlight some typical ultrasound findings of liver parenchyma and perihepatic lymph node structures in rare diffuse liver diseases based on a review of published data.

Zusammenfassung

Die transabdominelle Sonografie ist häufig das erste bildgebende Verfahren zur Evaluierung von Lebererkrankungen. Trotz Fortschritte der Gerätetechnologie ist die sonografische Diagnostik diffuser Lebererkrankungen schwierig. Dies liegt auch an den häufig nicht oder nur unspezifisch nachweisbaren Veränderungen der Leber. Erfassbare Veränderungen beinhalten die Lebergröße, Leberform, Echogenität, Analyse von intrahepatischen Gefäßen sowie die Beurteilung von perihepatischen Strukturen und Lymphknoten. Die häufig nur schwer zu erkennenden Veränderungen des Leberparenchyms wurden bisher kaum beschrieben. Aber auch bei selteneren diffusen Lebererkrankungen können typische sonografische Befunde erhoben werden. Die vorliegende Arbeit ist eine Literaturübersicht zu seltenen diffusen Lebererkrankungen und erläutert charakteristische sonomorphologische Befunde der einzelnen Krankheitsbilder.

Schlüsselwörter

Leitlinien - Morbus Wilson - Schistosomiasis - PSC - PBC - Virushepatitis - Autoimmunhepatitis

Key words

guidelines - Wilson’s disease - schistosomiasis - PSC - PBC - viral hepatitis - autoimmune hepatitis

Full Text

References

References
1 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
2 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34: 11-29
3 Sienz M, Ignee A, Dietrich CF. Reference values in abdominal ultrasound – liver and liver vessels. Z Gastroenterol 2010; 48: 1141-1152
4 Sienz M, Ignee A, Dietrich CF. Reference values in abdominal ultrasound – biliopancreatic system and spleen. Z Gastroenterol 2011; 49: 845-870
5 Dietrich CF, Schall H, Kirchner J et al. Sonographic detection of focal changes in the liver hilus in patients receiving corticosteroid therapy. Z Gastroenterol 1997; 35: 1051-1057
6 Hirche TO, Ignee A, Hirche H et al. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int 2007; 27: 748-757
7 Bamber J, Cosgrove D, Dietrich CF et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall in Med 2013; 34: 169-184
8 Cosgrove D, Piscaglia F, Bamber J et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall in Med 2013; 34: 238-253
9 Cui XW, Friedrich-Rust M, De Molo C et al. Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol 2013; 19: 6329-6347
10 Lyttkens K, Hannesson P, Prytz H et al. Lymph nodes in the hepato-duodenal ligament. A comparison between ultrasound and low-field MR imaging. Acta Radiol 1996; 37: 521-523
11 Metreweli C, Ward SC. Ultrasound demonstration of lymph nodes in the hepatoduodenal ligament ('Daisy Chain nodes') in normal subjects. Clin Radiol 1995; 50: 99-101
12 Dietrich CF, Lee JH, Herrmann G et al. Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 1997; 26: 467-472
13 Dietrich CF, Leuschner MS, Zeuzem S et al. Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease. Eur J Gastroenterol Hepatol 1999; 11: 747-753
14 Dietrich CF, Stryjek-Kaminska D, Teuber G et al. Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection. Am J Roentgenol Am J Roentgenol 2000; 174: 699-704
15 Dietrich CF, Viel K, Braden B et al. Mediastinal lymphadenopathy: an extrahepatic manifestation of chronic hepatitis C?. Z Gastroenterol 2000; 38: 143-152
16 Dietrich CF, Gottschalk R, Herrmann G et al. Sonographic detection of lymph nodes in the hepatoduodenal ligament. Dtsch Med Wochenschr 1997; 122: 1269-1274
17 Dietrich CF, Serra C, Jedrejczyk M. Ultrasound of the liver. In: Dietrich CF, editor. EFSUMB Course Book on Ultrasound. London: 2012: 31-90
18 Braden B, Faust D, Ignee A et al. Clinical relevance of perihepatic lymphadenopathy in acute and chronic liver disease. J Clin Gastroenterol 2008; 42: 931-936
19 Soresi M, Bonfissuto G, Sesti R et al. Perihepatic lymph nodes and antiviral response in chronic HCV-associated hepatitis. Ultrasound Med Biol 2004; 30: 711-717
20 Ignee A, Gebel M, Caspary WF et al. Doppler imaging of hepatic vessels – review. Z Gastroenterol 2002; 40: 21-32
21 Suk KT, Kim CH, Baik SK et al. Gallbladder wall thickening in patients with acute hepatitis. J Clin Ultrasound 2009; 37: 144-148
22 Tchelepi H, Ralls PW, Radin R et al. Sonography of diffuse liver disease. J Ultrasound Med 2002; 21: 1023-1032
23 Kaya S, Eskazan AE, Ay N et al. Acute acalculous cholecystitis due to viral hepatitis A. Case Rep Infect Dis 2013; 2013: 407182
24 Heller T, Brunetti E, Giordani MT et al. Ultrasound in tropical medicine. Human Immunodeficiency Virus (HIV) Infection. In: Dietrich CF, editor EFSUMB Course Book. London: EFSUMB; 2013: 1-22
25 Braden B, Helm B, Fabian T et al. Bacillary angiomatosis of the liver, a suspected ultrasound diagnosis?. Z Gastroenterol 2000; 38: 785-789
26 Barreiros AP, Braden B, Schieferstein-Knauer C et al. Characteristics of intestinal tuberculosis in ultrasonographic techniques. Scand J Gastroenterol 2008; 43: 1224-1231
27 Soresi M, Bonfissuto G, Magliarisi C et al. Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis. Clin Radiol 2003; 58: 372-377
28 Hirche TO, Russler J, Braden B et al. Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int J Colorectal Dis 2004; 19: 586-594
29 Vitellas KM, Enns RA, Keogan MT et al. Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. Am J Roentgenol Am J Roentgenol 2002; 178: 327-334
30 Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010; 139: 58-72
31 Manns MP, Czaja AJ, Gorham JD et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213
32 Richter J, Hatz C, Haussinger D. Ultrasound in tropical and parasitic diseases. Lancet 2003; 362 (9387) 900-902
33 Richter J, Lux J, Reinecke P et al. Of flukes and fistulae. Lancet 2008; 371 (9620) 1308
34 Strahan R, Chiyesu KO, Schneider-Kolsky ME. Ultrasound study of liver disease caused by Schistosoma mansoni in rural Zambian schoolchildren. J Med Imaging Radiat Oncol 2012; 56: 390-397
35 Silva LC, Andrade LM, de Paula IB et al. Ultrasound and magnetic resonance imaging findings in Schistosomiasis mansoni: expanded gallbladder fossa and fatty hilum signs. Rev Soc Bras Med Trop 2012; 45: 500-504
36 Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit. Diagnostik und Therapie der Schistosomiasis (Bilharziose). AWMF-S1-Leitlinie. online 042/05 2013
37 Rabello AL, da Silva RA, Rocha RS et al. Abdominal ultrasonography in acute clinical Schistosomiasis mansoni. Am J Trop Med Hyg 1994; 50: 748-752
38 Ramakrishna R, Gupta S, Sarathy K et al. Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): a non-invasive approach to clinical management. Intern Med J 2013; 43: 254-261
39 Gottschalk R, Wigand R, Dietrich CF et al. Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions. Clin Chim Acta 2000; 293: 127-138
40 Chu WC, Leung TF, Chan KF et al. Wilson’s disease with chronic active hepatitis: monitoring by in vivo 31-phosphorus MR spectroscopy before and after medical treatment. Am J Roentgenol Am J Roentgenol 2004; 183: 1339-1342
41 Akhan O, Akpinar E, Karcaaltincaba M et al. Imaging findings of liver involvement of Wilson’s disease. Eur J Radiol 2009; 69: 147-155
42 Akhan O, Akpinar E, Oto A et al. Unusual imaging findings in Wilson’s disease. Eur Radiol 2002; 12 (Suppl. 03) S66-S69
43 Vogel W, Kathrein H, Dietze O et al. Sonography of the liver in Wilson’s disease. Sonographic studies of the liver in Wilson’s disease – significance for assessing prognosis?. Ultraschall in Med 1988; 9: 270-273
44 Vogel W, Kathrein H, Dietze O et al. Ultrasonography in Wilson disease. Ann Intern Med 1988; 108: 769-770
45 Bonfissuto G, Magliarisi C, Soresi M et al. Wilson’s disease. Recenti Prog Med 1997; 88: 40-45
46 Dietrich CF, Rudd L. The EFSUMB website, a guide for better understanding. Med Ultrason 2013; 15: 215-223
47 Lee P, Mather S, Owens C et al. Hepatic ultrasound findings in the glycogen storage diseases. Br J Radiol 1994; 67: 1062-1066
48 Rake JP, Visser G, Labrune P et al. Guidelines for management of glycogen storage disease type I – European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002; 161 (Suppl. 01) S112-S119
49 Gossmann J, Scheuermann EH, Frilling A et al. Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease). Transplantation 2001; 72: 343-344
50 Visser G, Rake JP, Labrune P et al. Consensus guidelines for management of glycogen storage disease type 1b – European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 2002; 161 (Suppl. 01) S120-S123
51 Rake JP, Visser G, Labrune P et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002; 161 (Suppl. 01) S20-S34
52 Ryan CF, Sendi H, Bonkovsky HL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int 2012; 32: 880-893
53 Kersjes W, Harder T, Steudel A et al. Multiple circular liver foci in latent porphyria cutanea tarda. Rofo 1988; 148: 165-168
54 Sabate JM, Bourrier P, Vital JL et al. Images in hepatology. Multinodular focal fatty infiltration of the liver in acquired porphyria cutanea tarda. J Hepatol 2000; 33: 1022
55 Flueckiger F, Steiner H, Leitinger G et al. Nodular focal fatty infiltration of the liver in acquired porphyria cutanea tarda. Gastrointest Radiol 1991; 16: 237-239
56 Rickes S, Lochs H, Wermke W. Suspected liver metastases in a patient with porphyria cutanea tarda. Med Klin (Munich) 2001; 96: 414-415
57 Hadas-Halpern I, Deeb M, Abrahamov A et al. Gaucher disease: spectrum of sonographic findings in the liver. J Ultrasound Med 2010; 29: 727-733
58 Barreiros AP, Otto G, Ignee A et al. Sonographic signs of amyloidosis. Z Gastroenterol 2009; 47: 731-739
59 Dietrich CF, Caspary WF. SieScape--panorama imaging. Clinical value?. Internist (Berl) 2000; 41: 24-28
60 Dawwas MF, Davies SE, Griffiths WJ et al. Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease. Am J Respir Crit Care Med 2013; 187: 502-508
61 Dietrich CF, Chichakli M, Bargon J et al. Mediastinal lymph nodes demonstrated by mediastinal sonography: activity marker in patients with cystic fibrosis. J Clin Ultrasound 1999; 27: 9-14
62 Bargon J, Stein J, Dietrich CF et al. Gastrointestinal complications of adult patients with cystic fibrosis. Z Gastroenterol 1999; 37: 739-749
63 Dietrich CF, Chichakli M, Hirche TO et al. Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis. J Ultrasound Med 2002; 21: 409-416
64 Costa PC, Barreto CC, Pereira L et al. Cystic fibrosis-related liver disease: a single-center experience. Pediatr Rep 2011; 3: e21
65 Friedrich-Rust M, Schlueter N, Smaczny C et al. Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis. J Cyst Fibros 2013; 12: 431-439
66 Williams SM, Goodman R, Thomson A et al. Ultrasound evaluation of liver disease in cystic fibrosis as part of an annual assessment clinic: a 9-year review. Clin Radiol 2002; 57: 365-370
67 Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-1197
68 Polson J, Lee WM. Etiologies of acute liver failure: location, location, location!. Liver Transpl 2007; 13: 1362-1363
69 McDowell TD, Stevens RD, Gurakar A. Acute liver failure: a management challenge for the practicing gastroenterologist. Gastroenterol Hepatol (NY) 2010; 6: 444-450
70 Agarwal K, Jones DE, Burt AD et al. Metastatic breast carcinoma presenting as acute liver failure and portal hypertension. Am J Gastroenterol 2002; 97: 750-751
71 Lowenthal A, Tur-Kaspa R, Brower RG et al. Acute liver failure complicating ductal breast carcinoma: two cases and literature review. Scand J Gastroenterol 2003; 38: 1095-1096
72 Krauss EA, Ludwig PW, Sumner HW. Metastatic carcinoma presenting as fulminant hepatic failure. Am J Gastroenterol 1979; 72: 651-654
73 Woolf GM, Petrovic LM, Rojter SE et al. Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci 1994; 39: 1351-1358
74 Montero JL, Muntane J, de las HS et al. Acute liver failure caused by diffuse hepatic melanoma infiltration. J Hepatol 2002; 37: 540-541
75 Romero M, Palmer SL, Kahn JA et al. Imaging appearance in acute liver failure: correlation with clinical and pathology findings. Dig Dis Sci 2014; Apr 2. [Epub ahead of print]
76 Dietrich CF, Schuessler G, Trojan J et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704-707
77 Cui XW, Ignee A, Woenckhaus M et al. Hämangioendotheliom, eine bildgebende Herausforderung. Endo heute 2014; 27: 34-36
78 Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 2012; 57: 930-932
79 Piscaglia F, Nolsoe C, Dietrich CF et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall in Med 2012; 33: 33-59
80 Cui XW, Ignee A, Hocke M et al. Prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound. Ultraschall in Med 2014; 35: 246-252